Clinical trials
Enrolling by invitation Phase 3 trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
69 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 9 |
| 2023 | 9 |
| 2024 | 12 |
| 2025 | 16 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 69 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 3 |
| Axsome Therapeutics, Inc. | 3 |
| Biogen | 3 |
| Vertex Pharmaceuticals Incorporated | 3 |
| Campbell Clinic | 2 |
| LIB Therapeutics LLC | 2 |
| MoonLake Immunotherapeutics AG | 2 |
| Rothman Institute Orthopaedics | 2 |
| Sanofi | 2 |
| UCB Biopharma SRL | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Connective Tissue Diseases | 3 |
| Epilepsy | 3 |
| Lupus Erythematosus, Systemic | 3 |
| Neoplasms | 3 |
| Postoperative Pain | 3 |
| Seizures | 3 |
| Amyloidosis | 2 |
| Angioedemas, Hereditary | 2 |
| Hypercholesterolemia | 2 |
| Immune System Diseases | 2 |
Trials
Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.